IgM anti-GM1 antibodies in the Guillain-Barre syndrome: A serological predictor of the clinical course

Journal of Neuroimmunology

Volumn 72, Issue 1, 1997, Pages 59-66

  Bech, Einar ^a   Ørntoft, Torben F ^a   Andersen, Leif P ^b   Skinhøj, Peter ^b   Jakobsen, Johannes ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Campylobacter jejuni antibodies; GM1 antibodies; Guillain Barre syndrome

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGED; ARTICLE; CAMPYLOBACTER JEJUNI; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; AUTOANTIBODIES; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; DISEASE PROGRESSION; FEMALE; G(M1) GANGLIOSIDE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; POLYRADICULONEUROPATHY; PREDICTIVE VALUE OF TESTS;

EID: 0031021592     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00145-2     Document Type: Article

References (42)

1. Andersen, L.P. and Gaarslev, K. (1989) Campylobacter jejuni /coli: Elevated 1gA and IgM Antibodies During Acute Infection. Campylobacter V; Proc. V Th. Int. Workshop, pp. 221-222.
2. Arasaki, K., Kusunoki, S., Kudo, N. and Kanazawa, I. (1993) Acute conduction block in vitro following exposure to antiganglioside sera. Muscle Nerve 16, 587-593.
3. Arnason, B.G.W. and Soliven, B. (1993) In: ed. P.J. Dyck and P.K. Thomas, Peripheral Neuropathy, 3rd Ed. Saunders, Philadelphia, pp. 1437-1479.
4. Asbury, A.K., Arnason, B.G.W., Karp, H.R. and McFarlin, D.F.(1978) Criteria for diagnosis of Guillain-Barré syndrome. Ann. Neurol. 3, 565-566.
5. Asbury, A.K. and Cornblath, D.R. (1990) Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 27 Supp., S21-S24.
6. Aspinall, O.G., Fujimoto, S., McDonald, A.G., Pang, H., Kurjanczyk, L.A. and Penner, J.L. (1994) Lipopolysaccharides from Campylobacter jejuni associated with Guillian-Barré syndrome patients mimic human gangliosides in structure. Infect. Immun. 62, 2122-2125.
7. Bech, E., Jakobsen, J. and Ørntoft, T.F. (1994) ELISA-type titertray assay of IgM anti-GM1 autoantibodies. Clin. Chem. 40, 1331-1334.
8. van den Berg, L.H., Marrik, J., de Jager, A.E.J., et al. (1992) Anti-GM1 antibodies in patients with Guillian-Barré syndrome. J. Neurol. Neurosurg. Psychiatry 55, 8-12.
9. Corbo, M., Quattrini, A., Latov, N. and Hays, A.P. (1993) Localization of GM1 and Gal(b1-3)GalNAc antigenic determinants in peripheral nerve. Neurology 43, 809-814.
10. Enders, U., Karch, H., Toyka, K.V., Michels, M., Pette, M., Heesemann, J. and Hartung, H.P. (1993) The spectrum of immune responses to Campylobacter jejuni and Glycoconjungates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann. Neurol. 34, 136-144.
11. Fredman, P., Vedeler, C.A., Nyland, H., Aarli, J.A. and Svennerholm, L. (1991) Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin. J. Neurol. 238, 75-79.
12. Gregson, N.A., Jones, D., Thomas, P.K. and Willison, H.J. (1991) Acute motor neuropathy with antibodies to GM1 ganglioside. J. Neurol. 238, 447-451.
13. Gregson, N.A., Koblar, S. and Hughes, R.A.C. (1993) Antibodies to gangliosides in Guillain-Barre syndrome: Specificity and relationship to clinical features. Q. J. Med. 86, 111-117.
14. Griffin, J.W. and Ho, T.W. (1993) The Guillian-Barré syndrome at 75: The Campylobacter connection. Ann. Neurol. 34, 125-127.
15. Ilyas, A.A., Mithen, F.A., Dalakas, M.C., Chen, Z. and Cook, S.D. (1992) Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J. Neurol. Sci. 107, 111-121.
16. Kaldor, J. and Speed, B.R. (1984) Guillian-Barré syndrome and Campylobacter jejuni: A serological study, BMJ 288, 1867-1870.
17. Kinsella, J.L., Lange. D.L., Trojaborg, W., Sadiq, S.A., Younger, D.S. and Latov, N. (1994) Clinical and electrophysiological correlates of elevated anti-GM1 antibody titers. Neurology 44, 1278-1282.
18. Koski, C.L., Gratz, E., Sutherland J. and Mayer R.F. (1996) Clinical correlation with anti-peripheral-nerve myelin antibodies in Guillian-Barré syndrome. Ann. Neurol. 19, 573-577.
19. Kornberg, A.J., Pestronk, A., Bieser, K., Ho, T.W., McKhann, G.M., Wu, H.S. and Jiang, Z. (1994) The clinical correlates of high-tiler IgG anti-GM1 antibodies. Ann. Neurol. 35, 234-237.
20. Kuroki, S., Saida, T., Nukina, M., Haruta, T., Yoshioka, M., Kobayashi, Y. and Nakanishi, H. (1993) Campylobacter jejuni strains from patients with Guillian-Barré syndrome belong mostly to penner serogroup 19 and contain b-N-acetylglucosamin residues. Ann. Neurol. 33, 243-247.
21. Ledeen, R. (1985) Gangliosides of the neuron. TINS april, 169-174.
22. Li, Y., Månnsson, J.-E., Vanier, M.-T. and Svennerholm, L. (1973) Structure of the major ganglioside of human tissues. JBC 248, 2634-2636.
23. Marcus, D., Latov, N., Hsi, P.B. and Gillard, B.K. (1989) Measurement and significance of antibodies against GM1 ganglioside. J. Neuroimmunol. 25, 255-259.
24. Quartes, R.H. (1989) Myelin-associated glycoprotein in demyelinating disorders. Crit. Rev. Neurobiol. 5, 1-28.
25. Sadiq, S.A., Thomas, F.P., Kilidereas, K., Protopsaltis, S., Hays, A.P., Lee, K.W., Romas, S.N., Kumar, N., van den Berg, L., Santoro, M. et al. (1990) The spectrum of neurological disease associated with anti-GM1 antibodies. Neurology 40, 1067-1072.
26. 1 ganglioside antibody in patients with motor neuron disease and variants. Ann. Neurol. 27, 558-563.
27. Santoro, M., Thomas, F.P., Fink, M.E., Lange, D.J., Uncini, A., Wadia, N.H., Latov, N. and Hays, A.P. (1990) IgM deposits at the nodes of Randvier in a patient with amyotropic lateral sclerosis, anti-GM1 antibodies, and multifocal motor conduction block. Ann. Neurol. 28, 373-377.
28. Santoro, M., Uncini, A., Corbo, M., Staugaitis, S.M., Thomas, F.P., Hays, A.P. and Latov, N. (1992) Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann. Neurol. 31, 385-390.
29. Schwerer, B., Kitz, L.K. and Bernheimer, H. (1986) Ganglioside GM1, a molecular target for immunological and toxic attacks: Similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin. Acta Neuropathol. (Berlin) 72, 55-61.
30. Seiser, A., Potzl, G., Pichler, S., Bernheimer, H. and Schwerer, B. (1994) GM1 antibodies in Guillian-Barré syndrome: Isotypes, course and clinical outcome. Wien. Klin. Wochenschr. 106, 159-163.
31. Simone, I.L., Annunziata, P., Maimone, D., Liguori, M., Leante, R. and Livrea, P. (1993) Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J. Neurol. Sci. 114, 49-55.
32. The Guillain-Barré Syndrome Study Group (1985) Plasmapheresis and acute Guillain-Barré syndrome. Neurology 35, 1096-1104.
33. Thomas, F.P., Trojaborg, W., Nagy, C., Santoro, M., Sadiq, S.A., Latov, N. and Hays, A.P. ( 1991 ) Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the node of Ranvíer. Acta Neuropathol. 82, 378-383.
34. Rhodes, K.M. and Tattersfield, A.E. (1982) Guillain-Barre syndrome associated with Campylobacter infection. BMJ 285, 173-174.
35. Vriesendorp, F.J., Mishu, B., Blaser, M.J. and Koski, C.L. (1993) Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: Correlation and prognosis. Ann. Neurol. 34, 130-135.
36. Walsh, F.S., Cronin, M., Koblar, S., Doherty, P., Winer, J., Leon, A. and Hughes, R.A. (1991) Association between glycoconjungate antibodies and Campylobacter infection in patients with Guillian-Barre syndrome. J. Neuroimmunol. 34, 43-51.
37. Wirguin, I., Suturkova-Milosevic, L., Della-Latta, P., Fischer, T., Brown, R.H. and Latov, N. (1994) Monoclonal IgM antibodies to GM1 and asialo-GM1 in chronic neuropaties cross-react with Campylobacter jejuni lipopolysaccharides. Ann. Neurol. 35, 698-703.
38. Winer, J.B., Hughes, R.A.C. and Osmond, C. (1988) A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J. Neurol. Neurosurg. Psychiatry 51, 605-612.
39. Zielasek, J., Ritter, G., Magi, S., Hartung, H. and Toyka, K.V. (1994) A comparative trial of anti-glycoconjugate antibody assays: IgM antibodies to GM1. J. Neurol. 241, 475-480.
40. von Wulffen, H., Hartard, C. and Scharein, E. (1994) Seroreactivity to Campylobacter jejuni and gangliosides in patients with Guillain-Barre syndrome. J. Infect. Dis. 170, 828-833.
41. Yuki, N., Taki, T., Inagaki, F., Kasama, T., Takahashi, M., Saito, K., Handa, S. and Miyatake, T. (1993) A bacterium lipopolysccharide that elicit Guillain-Barré syndrome has a GM1 ganglioside-like structure. 178(5), 1771-1775.
42. Yuki, N., Yoshino, H., Sato, S. and Miyatake, T. (1990) Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 40, 1900-1902.